Tanvex BioPharma Inc (6541) — Working Capital to Net Assets Ratio
Tanvex BioPharma Inc (6541) has a Working Capital to Net Assets ratio of 12.3% as of December 2025. Working capital of NT$697.52 Million (current assets of NT$1.50 Billion minus current liabilities of NT$799.66 Million) is measured against net assets of NT$5.69 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 6541 equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tanvex BioPharma Inc Working Capital to Net Assets (2013–2025)
This chart shows how Tanvex BioPharma Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 12.3%, reflecting working capital of NT$697.52 Million against net assets of NT$5.69 Billion TWD. Check Tanvex BioPharma Inc (6541) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Tanvex BioPharma Inc (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tanvex BioPharma Inc from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Tanvex BioPharma Inc stock valuation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 12.3% | NT$697.52 Million | NT$5.69 Billion | NT$1.50 Billion | NT$799.66 Million | ▼ -24.4 pp |
| 2024 | 36.7% | NT$327.48 Million | NT$893.31 Million | NT$675.62 Million | NT$348.14 Million | ▲ +7.4 pp |
| 2023 | 29.3% | NT$240.48 Million | NT$821.11 Million | NT$604.21 Million | NT$363.73 Million | ▼ -23.9 pp |
| 2022 | 53.2% | NT$740.43 Million | NT$1.39 Billion | NT$1.04 Billion | NT$303.29 Million | ▼ -23.8 pp |
| 2021 | 77.1% | NT$2.15 Billion | NT$2.79 Billion | NT$2.40 Billion | NT$248.51 Million | ▲ +4.2 pp |
| 2020 | 72.9% | NT$1.91 Billion | NT$2.62 Billion | NT$2.26 Billion | NT$353.10 Million | ▼ -4.1 pp |
| 2019 | 77.0% | NT$2.33 Billion | NT$3.03 Billion | NT$2.60 Billion | NT$270.45 Million | ▼ -5.7 pp |
| 2018 | 82.7% | NT$3.49 Billion | NT$4.21 Billion | NT$3.70 Billion | NT$209.46 Million | ▲ +2.4 pp |
| 2017 | 80.3% | NT$3.01 Billion | NT$3.75 Billion | NT$3.18 Billion | NT$164.70 Million | ▲ +4.2 pp |
| 2016 | 76.1% | NT$2.72 Billion | NT$3.57 Billion | NT$2.95 Billion | NT$233.15 Million | ▲ +29.3 pp |
| 2015 | 46.8% | NT$678.07 Million | NT$1.45 Billion | NT$780.47 Million | NT$102.40 Million | ▲ +17.4 pp |
| 2014 | 29.4% | NT$173.55 Million | NT$589.64 Million | NT$218.43 Million | NT$44.88 Million | ▼ -0.3 pp |
| 2013 | 29.8% | NT$120.18 Million | NT$403.64 Million | NT$182.77 Million | NT$62.59 Million | — |